Investment management company Ave Maria recently released its “Ave Maria Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund ...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
AptarGroup is poised for growth in its Pharma and Closure segments, but challenges are expected in the Beauty segment. The prescription drug business is expected to drive revenue growth in the Pharma ...
We recently published a list of 7 Best Boring Stocks to Buy. In this article, we are going to take a look at where AptarGroup Inc. (NYSE:ATR) stands against other best boring stocks to buy. “Boring” ...
AptarGroup (ATR) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its ...
AptarGroup has delivered steady, consistent revenue and margin growth, though it has underperformed the S&P 500 over the past decade. Gross profit margin and return on invested capital have improved ...
Yousif Capital Management LLC decreased its holdings in AptarGroup, Inc. (NYSE:ATR – Free Report) by 2.2% in the 1st quarter, HoldingsChannel reports. The firm owned 23,465 shares of the industrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback